- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 407/04
Total number of patents in this class: 735
10-year publication summary
|
42
|
48
|
51
|
40
|
51
|
37
|
41
|
45
|
36
|
32
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 18010 |
21 |
| Merck Patent GmbH | 5772 |
21 |
| Daewoong Pharmaceutical Co., Ltd. | 374 |
14 |
| Janssen Pharmaceutica N.V. | 3110 |
10 |
| F. Hoffmann-La Roche AG | 7776 |
9 |
| Green Cross Corporation | 218 |
9 |
| SynDevRx, Inc. | 52 |
9 |
| Hoffmann-La Roche Inc. | 3885 |
8 |
| BASF SE | 21337 |
8 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 129 |
8 |
| LT Materials Co., Ltd. | 443 |
8 |
| Centre National de La Recherche Scientifique | 11171 |
7 |
| SFC Co., Ltd. | 341 |
7 |
| Tokuyama Corporation | 1507 |
7 |
| Novartis AG | 10162 |
6 |
| Bristol-myers Squibb Company | 4758 |
6 |
| Syngenta Participations AG | 1438 |
6 |
| Amgen Inc. | 4499 |
6 |
| Cumberland Pharmaceuticals Inc. | 66 |
6 |
| FMC Corporation | 817 |
6 |
| Other owners | 553 |